Medicinal Products

Kventiax SR 150 mg tablete s produljenim oslobađanjem

Name Kventiax SR 150 mg tablete s produljenim oslobađanjem
Marketing Authorisation Number HR-H-547747784
Active Substance kvetiapinfumarat
Composition svaka tableta s produljenim oslobađanjem sadrži 150 mg kvetiapina u obliku kvetiapinfumarata
Pharmaceutical Form tableta s produljenim oslobađanjem
Packaging [MA Number for Packaging] 10 tableta u blisteru, u kutiji  [HR-H-547747784-01]
30 tableta u blisteru, u kutiji  [HR-H-547747784-02]
50 tableta u blisteru, u kutiji  [HR-H-547747784-03]
60 tableta u blisteru, u kutiji  [HR-H-547747784-04]
90 tableta u blisteru, u kutiji  [HR-H-547747784-05]
100 tableta u blisteru, u kutiji  [HR-H-547747784-06]
Manufacturer Krka d.d., Novo mesto, Novo Mesto, Slovenija
Marketing Authorisation Holder Krka - farma d.o.o., Radnička cesta 48, Zagreb, Hrvatska
Marketing Authorisation Date 17.07.2020
MA Period of Validity unlimited
Classification Number UP/I-530-09/19-02/166
Registration Number 381-12-01/38-20-03
Prescription na recept
Type of prescription ponovljivi recept
Distribution u ljekarni
Advertising to general public zabranjeno
ATC Code N05AH04
Medicinal product marketed in the Croatia Da
SmPC download
PL download
Educational materials
for healthcare professionals
Podsjetnik o važnosti nadziranja metaboličkih parametara tijekom liječenja kvetiapinom, verzija 2
Back